Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from CVS Group plc ( (GB:CVSG) ) is now available.
CVS Group plc announced that Paul Higgs, Director and Chief Veterinary Officer, and Joanne Shaw, Non-Executive Director, have purchased additional shares in the company. These transactions slightly increase their respective stakes in CVS, reflecting continued confidence in the company’s prospects and potentially impacting stakeholder perceptions positively.
The most recent analyst rating on (GB:CVSG) stock is a Hold with a £1420.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.
Spark’s Take on GB:CVSG Stock
According to Spark, TipRanks’ AI Analyst, GB:CVSG is a Neutral.
CVS Group plc’s overall stock score reflects a mixed outlook. Financial performance is strong in revenue growth but challenged by profitability issues. Technical indicators show short-term bearish trends, and valuation suggests overvaluation. However, positive corporate events and strategic moves support long-term growth prospects.
To see Spark’s full report on GB:CVSG stock, click here.
More about CVS Group plc
CVS Group plc is a UK-listed veterinary group that provides veterinary services. It is a leading provider in its industry, focusing on offering comprehensive veterinary care.
Average Trading Volume: 449,459
Technical Sentiment Signal: Buy
Current Market Cap: £861.9M
See more data about CVSG stock on TipRanks’ Stock Analysis page.